サインイン 無料でサインアップします。

AMAG Pharmaceuticalsの1年間の目標

AMAG Pharmaceuticalsの1年間の目標は何ですか。

AMAG Pharmaceuticals, Inc.の1年間の目標は$13 -47.52%です。

1年間の目標の定義は何ですか。

1年目標は今から1年後の予測株価です。

One year target is an estimate of a stock price for a point in time equal to a year from the current date. The price level most often reflects the collective opinion of different analysts on where the stock will be trading a year from now. For an analyst to identify an individual estimate, they have to project what a company’s business will look like in a year, typically focusing on revenue and other significant factors. They also consider the willingness of investors to pay a certain price. While the average or median recommendation may be predictive and reflect the actual future value, the results are usually not extremely successful.

NASDAQのセクタHealth Careにおける1年間の目標の企業と比べるAMAG Pharmaceuticals

AMAG Pharmaceuticalsは何をしますか。

AMAG Pharmaceuticals, Inc. is a biopharmaceutical company. It focuses on the manufacture, development, and commercialization of a therapeutic iron compound to treat iron deficiency anemia. The firm focuses on the development and commercialization of Feraheme injection for intravenous use to treat iron deficiency anemia. It manufactures, develops, and commercializes products derived from its proprietary technology for use in treating human diseases. Its products include Intrarosa, Vyleesi, Makena, CBR, Feraheme, and MuGard. The company was founded on November 9, 1981 and is headquartered in Waltham, MA.

AMAG Pharmaceuticalsと類似の1年間の目標